|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocm57572610 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
050205s2004 maua fob 100 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d N$T
|d HALAN
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCQ
|d SAV
|d VNS
|d VTS
|d AGLDB
|d INT
|d REC
|d OCLCQ
|d MITPR
|d G3B
|d UKAHL
|d OCLCO
|d K6U
|d OCLCQ
|d QGK
|d OCLCO
|
019 |
|
|
|a 144561926
|a 531340244
|a 630217500
|a 1259109313
|
020 |
|
|
|a 9780262271059
|q (electronic bk.)
|
020 |
|
|
|a 0262271052
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000072079883
|
029 |
1 |
|
|a DEBBG
|b BV043093437
|
029 |
1 |
|
|a DEBSZ
|b 422337463
|
029 |
1 |
|
|a GBVCP
|b 801250250
|
035 |
|
|
|a (OCoLC)57572610
|z (OCoLC)144561926
|z (OCoLC)531340244
|z (OCoLC)630217500
|z (OCoLC)1259109313
|
037 |
|
|
|a 3153
|b MIT Press
|
037 |
|
|
|a 9780262271059
|b MIT Press
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a HG9396
|b F76eb 2004
|
072 |
|
7 |
|a BUS
|x 033040
|2 bisacsh
|
082 |
0 |
4 |
|a 368.38200973
|2 22
|
049 |
|
|
|a UAMI
|
111 |
2 |
|
|a Frontiers in Health Policy Research Conference
|n (7th :
|d 2003 :
|c Washington, D.C.)
|
245 |
1 |
0 |
|a Frontiers in health policy research.
|n vol. 7 /
|c edited by David M. Cutler and Alan M. Garber.
|
260 |
|
|
|a Cambridge, Mass. :
|b MIT Press,
|c 2004.
|
300 |
|
|
|a 1 online resource (1 volume) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a "National Bureau of Economic Research."
|
500 |
|
|
|a These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003.
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
0 |
|t Introduction /
|r David M. Cutler and Alan M. Garber --
|t Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New Zealand /
|r Patricia M. Danzon and Jonathan D. Ketcham --
|t Adverse selection and the challenges to stand-alone prescription drug insurance /
|r Mark V. Pauly and Yuhui Zeng --
|t Disability forecasts and future medicare costs /
|r Jayanta Bhattacharya [and others] --
|t Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? /
|r William H. Crown [and others] --
|t An economic analysis of health plan conversions: are they in the public interest? /
|r Nancy Dean Beaulieu.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a This series from the NBER presents new research by leading economists on current health care policy issues. The papers in this seventh volume, originally presented at the annual Frontiers in Health Policy Research conference held in Washington D.C. in the summer of 2003, reflect the economic challenges faced by policymakers and health care professionals in an age of budget deficits. Topics discussed include prescription drug benefits as a stand-alone component of Medicare, disability rates and Medicare costs, and conversion to for-profit health plans.
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Health insurance
|z United States
|v Congresses.
|
650 |
|
0 |
|a Drugs
|x Prices
|z United States
|v Congresses.
|
650 |
|
0 |
|a Pharmaceutical services insurance
|z United States
|v Congresses.
|
650 |
|
0 |
|a Medicare
|z United States
|x Costs
|v Congresses.
|
650 |
|
0 |
|a Nonprofit organizations
|z United States
|v Congresses.
|
650 |
|
0 |
|a Privatization
|z United States
|v Congresses.
|
650 |
|
0 |
|a Insurance
|z United States
|x Plans
|v Congresses.
|
650 |
|
0 |
|a Medical policy
|z United States
|v Congresses.
|
650 |
|
0 |
|a Medical policy
|x Economic aspects
|z United States
|v Congresses.
|
650 |
|
0 |
|a Medical economics
|z United States
|v Congresses.
|
650 |
|
0 |
|a Medicare
|x Costs
|v Congresses.
|
650 |
|
6 |
|a Assurance-maladie
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Médicaments
|x Prix
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Assurance-médicaments
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Medicare
|x Coût
|v Congrès.
|
650 |
|
6 |
|a Associations sans but lucratif
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Privatisation
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Politique sanitaire
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Politique sanitaire
|x Aspect économique
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Économie de la santé
|z États-Unis
|v Congrès.
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Insurance
|x Health.
|2 bisacsh
|
650 |
|
7 |
|a Drugs
|x Prices
|2 fast
|
650 |
|
7 |
|a Health insurance
|2 fast
|
650 |
|
7 |
|a Insurance
|x Plans
|2 fast
|
650 |
|
7 |
|a Medical economics
|2 fast
|
650 |
|
7 |
|a Medical policy
|2 fast
|
650 |
|
7 |
|a Medical policy
|x Economic aspects
|2 fast
|
650 |
|
7 |
|a Medicare
|x Costs
|2 fast
|
650 |
|
7 |
|a Nonprofit organizations
|2 fast
|
650 |
|
7 |
|a Pharmaceutical services insurance
|2 fast
|
650 |
|
7 |
|a Privatization
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|
653 |
|
|
|a ECONOMICS/Health Economics
|
653 |
|
|
|a SOCIAL SCIENCES/Political Science/Public Policy & Law
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
700 |
1 |
|
|a Cutler, David M.
|
700 |
1 |
|
|a Garber, Alan M.
|
710 |
2 |
|
|a National Bureau of Economic Research.
|
776 |
0 |
8 |
|i Print version:
|a Frontiers in Health Policy Research Conference (7th : 2003 : Washington, D.C.).
|t Frontiers in health policy research. vol. 7.
|d Cambridge, Mass. : MIT Press, 2004
|z 0262033259
|z 0262532662
|w (OCoLC)56660305
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=125994
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH37586317
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 125994
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2354101
|
994 |
|
|
|a 92
|b IZTAP
|